Literature DB >> 24327477

Maternal obesity and risk of Down syndrome in the offspring.

Eric Hildebrand1, Bengt Källén, Ann Josefsson, Tomas Gottvall, Marie Blomberg.   

Abstract

OBJECTIVE: The objective of this article is to determine if maternal obesity is associated with an increased risk of Down syndrome in the offspring and whether the risk estimates for trisomy 21 based on combined screening is affected by maternal body mass index (BMI).
METHODS: Study group I consisted of a nationwide cohort of 1 568 604 women giving birth; outcome was infants born with Down syndrome [Correction made here after initial online publication.]. Adjustment was made for maternal age. Study group II consisted of 10 224 women undergoing 1st trimester combined screening. Outcome was risk assessment for Down syndrome. All women were divided into six BMI groups, and outcomes were evaluated over the BMI strata with BMI 18.5 to 24.9 as reference and correcting for maternal age.
RESULTS: Obese women had an increased risk for giving birth to an infant with Down syndrome compared with normal-weight women, BMI 30 to 34.9 odds ratio (OR) 1.31 [95% confidence interval (CI) 1.10-1.55], BMI 35 to 39.9 OR 1.12 (95% CI 0.82-1.53), BMI ≥ 40 OR 1.56 (95% CI 1.00-2.43). The observed and the expected numbers of women with a risk of Down syndrome >1/300 based on 1st trimester combined screen and maternal age were similar in each BMI group.
CONCLUSION: Maternal obesity seems to increase the risk for Down syndrome births. The risk estimate for Down syndrome with 1st trimester combined screening is unaffected by BMI.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24327477     DOI: 10.1002/pd.4294

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

Review 1.  Obesity in Pregnancy: Optimizing Outcomes for Mom and Baby.

Authors:  Heidi Dutton; Sarah Jean Borengasser; Laura Marie Gaudet; Linda A Barbour; Erin Joanne Keely
Journal:  Med Clin North Am       Date:  2018-01       Impact factor: 5.456

2.  A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy.

Authors:  Yiming Chen; Bin Wu; Yijie Chen; Wenwen Ning; Huimin Zhang
Journal:  Reprod Sci       Date:  2021-11-08       Impact factor: 3.060

3.  Maternal pre-pregnancy and gestational diabetes, obesity, gestational weight gain, and risk of cancer in young children: a population-based study in California.

Authors:  Zuelma A Contreras; Beate Ritz; Jasveer Virk; Myles Cockburn; Julia E Heck
Journal:  Cancer Causes Control       Date:  2016-09-09       Impact factor: 2.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.